APA (7th ed.) Citation

Naeimi, A., Saedi, H. S., Bakhtiyari, A. M., Shabani, K., Babajani, Z., & Zahmatkesh, M. H. (2026). The combination of rosuvastatin and meloxicam enhances the radiotherapy efficacy of MCF7, T-47D, and MDA-MB-231 breast cancer cell lines. Research in Pharmaceutical Sciences, 21(1), 96. https://doi.org/10.4103/RPS.RPS_191_24

Chicago Style (17th ed.) Citation

Naeimi, Arvin, Hamid Saeidi Saedi, Amir Mohsen Bakhtiyari, Kimia Shabani, Zahra Babajani, and Mona Haddad Zahmatkesh. "The Combination of Rosuvastatin and Meloxicam Enhances the Radiotherapy Efficacy of MCF7, T-47D, and MDA-MB-231 Breast Cancer Cell Lines." Research in Pharmaceutical Sciences 21, no. 1 (2026): 96. https://doi.org/10.4103/RPS.RPS_191_24.

MLA (9th ed.) Citation

Naeimi, Arvin, et al. "The Combination of Rosuvastatin and Meloxicam Enhances the Radiotherapy Efficacy of MCF7, T-47D, and MDA-MB-231 Breast Cancer Cell Lines." Research in Pharmaceutical Sciences, vol. 21, no. 1, 2026, p. 96, https://doi.org/10.4103/RPS.RPS_191_24.